Geneos Wealth Management’s Accenture ACN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.61M Buy
28,284
+2,107
+8% +$491K 0.13% 190
2025
Q4
$7.02M Sell
26,177
-238
-0.9% -$60.5K 0.17% 146
2025
Q3
$6.51M Buy
26,415
+117
+0.4% +$30.5K 0.17% 155
2025
Q2
$7.86M Sell
26,298
-16,472
-39% -$5.02M 0.19% 133
2025
Q1
$13.7M Buy
42,770
+29,260
+217% +$10.3M 0.2% 128
2024
Q4
$4.75M Buy
13,510
+284
+2% +$102K 0.17% 144
2024
Q3
$4.68M Buy
13,226
+1,212
+10% +$399K 0.18% 136
2024
Q2
$3.65M Buy
12,014
+670
+6% +$205K 0.16% 143
2024
Q1
$3.93M Buy
11,344
+112
+1% +$40.8K 0.18% 143
2023
Q4
$3.94M Sell
11,232
-117
-1% -$37.7K 0.19% 129
2023
Q3
$3.49M Buy
11,349
+328
+3% +$103K 0.18% 145
2023
Q2
$3.4M Buy
11,021
+632
+6% +$184K 0.18% 147
2023
Q1
$2.97M Sell
10,389
-1,839
-15% -$501K 0.18% 144
2022
Q4
$3.26M Buy
12,228
+521
+4% +$144K 0.2% 128
2022
Q3
$3.01M Sell
11,707
-2,211
-16% -$639K 0.21% 120
2022
Q2
$3.91M Buy
13,918
+327
+2% +$98.3K 0.19% 123
2022
Q1
$4.58M Buy
13,591
+1,842
+16% +$621K 0.2% 121
2021
Q4
$4.87M Buy
11,749
+196
+2% +$71.4K 0.19% 127
2021
Q3
$3.75M Buy
11,553
+644
+6% +$209K 0.14% 161
2021
Q2
$3.33M Sell
10,909
-1,331
-11% -$381K 0.13% 171
2021
Q1
$3.55M Sell
12,240
-839
-6% -$217K 0.1% 212
2020
Q4
$2.96M Buy
13,079
+2,015
+18% +$483K 0.12% 187
2020
Q3
$2.38M Buy
11,064
+927
+9% +$212K 0.12% 180
2020
Q2
$2.15M Buy
10,137
+2,048
+25% +$387K 0.12% 181
2020
Q1
$1.32M Sell
8,089
-1,226
-13% -$236K 0.09% 222
2019
Q4
$1.98M Buy
9,315
+955
+11% +$186K 0.11% 208
2019
Q3
$1.6M Buy
8,360
+1,441
+21% +$279K 0.1% 206
2019
Q2
$1.28M Buy
6,919
+1,445
+26% +$260K 0.08% 233
2019
Q1
$904K Buy
5,474
+2,113
+63% +$332K 0.06% 282
2018
Q4
$480K Buy
3,361
+1,418
+73% +$224K 0.04% 385
2018
Q3
$337K Buy
1,943
+393
+25% +$65.4K 0.02% 479
2018
Q2
$253K Sell
1,550
-569
-27% -$88.5K 0.02% 500
2018
Q1
$325K Sell
2,119
-167
-7% -$26.5K 0.03% 397
2017
Q4
$350K Buy
2,286
+51
+2% +$7.39K 0.03% 396
2017
Q3
$301K Sell
2,235
-13
-0.6% -$1.69K 0.03% 403
2017
Q2
$278K Buy
2,248
+8
+0.4% +$975 0.03% 414
2017
Q1
$268K Buy
2,240
+66
+3% +$7.88K 0.03% 405
2016
Q4
$254K Sell
2,174
-673
-24% -$79.9K 0.03% 406
2016
Q3
$347K Buy
2,847
+31
+1% +$3.53K 0.05% 319
2016
Q2
$319K Buy
2,816
+7
+0.2% +$812 0.05% 330
2016
Q1
$326K Buy
+2,809
New +$289K 0.05% 319

Other funds holding ACN

Geneos Wealth Management's ACN Position: Q1 2026 in Review

Geneos Wealth Management increased its Accenture (ACN) stake by 8% in Q1 2026, buying an estimated $491K and bringing the position to 28,284 shares worth $5.61M. The position accounts for 0.13% of the portfolio, ranked #190.

Geneos Wealth Management first reported a position in ACN in Q1 2016 and has held it in 41 quarters since. The position peaked at $13.7M in Q1 2025. 2,149 funds tracked by Wall St. Rank hold ACN as of Q1 2026.

  • Geneos Wealth Management held 28,284 shares of Accenture worth $5.61M as of Q1 2026.
  • Geneos Wealth Management bought 2,107 Accenture shares in Q1 2026, an estimated $491K.
  • Accenture made up 0.13% of Geneos Wealth Management's portfolio in Q1 2026, its #190 holding.
  • Geneos Wealth Management first reported a position in Accenture in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's Accenture position peaked at $13.7M in Q1 2025.
  • 2,149 funds tracked by Wall St. Rank held Accenture as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.